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Systems to Facilitate Adult Stem Cell Seeding and Conditioning of Aortic Heart Valve Scaffolds
Lee Sierad, Richard Pascal, Dr. Agneta Simionescu, & Dr. Dan Simionescu
Background

Cell Seeding System

 Cardiovascular disease causes 750,000 deaths annually in the US1
 Valvular heart disease is characterized by abnormal tissue stiffness and
calcification, stenosis, or thromboembolism of valve leaflets, which can
limit the functionality of aortic valves.1
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A) Bioreactor components B) Endothelial cell seeded TEHV C) Stented bioprosthetic heart valve D) Diagram of conditioning system

 A common treatment is replacement with either a mechanical or tissuederived heart valve.
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 Existing heart valve replacements provide major improvements in
cardiac function and life expectancy, but have significant limitations and
eventually require surgical replacement within 15-20 years.
Mechanical
requires life-long
anticoagulation therapy

Tissue-derived
subject to degeneration
and calcification

 In pediatric patients, mechanical implants are naturally outgrown and
degradation and calcification of tissue-derived implants is accelerated.
 A tissue engineered heart valve (TEHV) replacement with the
capabilities of remodeling and growing with the patient would alleviate
these problems.
 A device for uniform cell seeding will be required to facilitate the
development of an autologous TEHV in the areas of:
Decelled TEHV
 Depositing a confluent layer of cells on all surfaces.
 Improving cell seeding efficiency and uniformity
over manual seeding regardless of user variations.
 Providing conditions under which varying attachment
improvements can be evaluated and compared.
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TEHV Generation, Seeding, &Testing
 Porcine aortic heart valves were decellularized to remove the porcinespecific antigens,2 sterilized using peracetic acid, and stabilized with
pentagalloyl glucose to control tissue degradation.
 Valve surfaces were incubated in 50% serum in cell culture medium
overnight to neutralize any remaining pentagalloyl glucose molecules
then coated with Fibronectin or Pronectin to improve cell attachment.
 Valves were mounted in individual seeding chambers, seeded with 15 to
24 million porcine aortic endothelial cells (pAECs) or human adipose
derived stem cells (hASCs), and rotated according to multiple regimens.
 Cell seeded valves were placed in a dynamic heart valve bioreactor
under pulmonary or aortic pressures.
 Valves were evaluated for initial attachment, retention after bioreactor
testing, and viability throughout.
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Conclusions
 The treated surface was compatible with both cell types.
 Device design and protocol enabled a reproducible & semi-automated seeding process.
 Made progress toward achieving a confluent valvular endothelium layer.
 Cells were retained on the scaffold surface under pulmonary pressure conditioning in
the bioreactor.
 Surface seeding has been successful with two cell types and is quickly progressing
toward a translational regenerative TEHV fully seeded with the patient’s own cells.
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